Lista de obras - Vrablik Michal - Dominio Público Uruguay

A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy.

artículo científico

APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels

artículo científico publicado en 2008

APOA5 haplotypes determine triglyceride decrease after lifestyle induced weight loss in children

artículo científico publicado en 2012

Association between polymorphism within the RYR2 receptor and development of statin-associated myalgia/myopathy in the Czech population

article

Atorvastatin reduces expression of leukocyte adhesion molecules in patients with hypercholesterolemia.

artículo científico publicado en 2003

Changes in Hemostatic Variables Induced by Estrogen Replacement Therapy: Comparison of Transdermal and Oral Administration in a Crossover-Designed Study

artículo científico publicado en 2007

Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries

scientific article published on 15 November 2019

Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia

artículo científico publicado en 2016

Effect of apolipoprotein E polymorphism on statin-induced decreases in plasma lipids and cardiovascular events

artículo científico publicado en 2011

Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding

artículo científico publicado en 2008

FTO and MC4R gene variants determine BMI changes in children after intensive lifestyle intervention

article

Familial defective apolipoprotein B-100 homozygote with premature coronary atherosclerosis. A case report 1

artículo científico publicado en 1999

Folic acid does not improve surrogate markers of early atherosclerosis in atorvastatin-treated patients

Gene variants at FTO, 9p21, and 2q36.3 are age-independently associated with myocardial infarction in Czech men

article

Genetic determination of triglyceridemia with special focus on apolipoprotein gene variants

article

Hypertriglyceridemia: interaction between APOE and APOAV variants

artículo científico publicado en 2005

Impact of apolipoprotein A5 variants on statin treatment efficacy

artículo científico publicado en 2009

Increase of inflammatory state in overweight adults with combined hyperlipidemia.

artículo científico publicado en 2003

Interaction of common sequence variants and selected risk factors in determination of HDL cholesterol levels

artículo científico publicado en 2010

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

artículo científico publicado en 2017

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

artículo científico publicado en 2017

Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipoprotein cholesterol

artículo científico

MLXIPL variant in individuals with low and high triglyceridemia in white population in Central Europe

article by Michal Vrablík et al published 23 October 2008 in Human Genetics

New strategies in the treatment of dyslipidemia: do we know how?

artículo científico publicado en 2004

Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.

artículo científico publicado en 2008

Plasma HDL-cholesterol and triglyceride levels in familial hypercholesterolemia: data from the MedPed CZ database and the Czech population.

artículo científico publicado en 2011

Rare variants in known and novel candidate genes predisposing to statin-associated myopathy.

artículo científico publicado en 2016

Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry

scholarly article by Michal Vrablík et al published October 2018 in Atherosclerosis

SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population

artículo científico publicado en 2015

Ser19-->Trp polymorphism within the apolipoprotein AV gene in hypertriglyceridaemic people

artículo científico publicado en 2003

The Role of Nutraceuticals in Statin Intolerant Patients

The authors of lipid guidelines are at odds with their own recommendations

The impact of rapid weight loss on oxidative stress markers and the expression of the metabolic syndrome in obese individuals.

artículo científico publicado en 2013

Use of ezetimibe results in more patients reaching lipid targets without side effects

Variant within CELSR2/PSRC1/SORT1, but not within CILP2/PBX4, PCSK9 and APOB genes, has a potential to influence statin treatment efficacy

article

Lista de obras de Vrablik Michal

A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy.

APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels

APOA5 haplotypes determine triglyceride decrease after lifestyle induced weight loss in children

Association between polymorphism within the RYR2 receptor and development of statin-associated myalgia/myopathy in the Czech population

Atorvastatin reduces expression of leukocyte adhesion molecules in patients with hypercholesterolemia.

Changes in Hemostatic Variables Induced by Estrogen Replacement Therapy: Comparison of Transdermal and Oral Administration in a Crossover-Designed Study

Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries

Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia

Effect of apolipoprotein E polymorphism on statin-induced decreases in plasma lipids and cardiovascular events

Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding

FTO and MC4R gene variants determine BMI changes in children after intensive lifestyle intervention

Familial defective apolipoprotein B-100 homozygote with premature coronary atherosclerosis. A case report 1

Folic acid does not improve surrogate markers of early atherosclerosis in atorvastatin-treated patients

Gene variants at FTO, 9p21, and 2q36.3 are age-independently associated with myocardial infarction in Czech men

Genetic determination of triglyceridemia with special focus on apolipoprotein gene variants

Hypertriglyceridemia: interaction between APOE and APOAV variants

Impact of apolipoprotein A5 variants on statin treatment efficacy

Increase of inflammatory state in overweight adults with combined hyperlipidemia.

Interaction of common sequence variants and selected risk factors in determination of HDL cholesterol levels

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipoprotein cholesterol

MLXIPL variant in individuals with low and high triglyceridemia in white population in Central Europe

New strategies in the treatment of dyslipidemia: do we know how?

Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.

Plasma HDL-cholesterol and triglyceride levels in familial hypercholesterolemia: data from the MedPed CZ database and the Czech population.

Rare variants in known and novel candidate genes predisposing to statin-associated myopathy.

Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry

SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population

Ser19-->Trp polymorphism within the apolipoprotein AV gene in hypertriglyceridaemic people

The Role of Nutraceuticals in Statin Intolerant Patients

The authors of lipid guidelines are at odds with their own recommendations

The impact of rapid weight loss on oxidative stress markers and the expression of the metabolic syndrome in obese individuals.

Use of ezetimibe results in more patients reaching lipid targets without side effects

Variant within CELSR2/PSRC1/SORT1, but not within CILP2/PBX4, PCSK9 and APOB genes, has a potential to influence statin treatment efficacy